André B. P. Kuilenburg

Researcher Next ID · RN-033561

Researcher · Biochemistry, Genetics and Molecular Biology

Amsterdam, Netherlands

Accepting doctoral researchersFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Biochemical and Molecular Research

Metabolism and Genetic Disorders

Colorectal Cancer Treatments and Studies

Neonatal Health and Biochemistry

Cancer therapeutics and mechanisms

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis
The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30686-7
Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data
The Lancet Oncology · 2015 · https://doi.org/10.1016/s1470-2045(15)00286-7
Thalassemia Syndromes
Journal · 2009 · https://doi.org/10.1007/978-3-540-29676-8_1731
Histone deacetylases (HDACs): characterization of the classical HDAC family
Biochemical Journal · 2003 · https://doi.org/10.1042/bj20021321
Lethal outcome of a patient with a complete dihydropyrimidine dehydrogenase (DPD) deficiency after administration of 5-fluorouracil: frequency of the common IVS14+1G>A mutation causing DPD deficiency.
PubMed · 2001
Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency
Human Genetics · 1999 · https://doi.org/10.1007/pl00008711
Reduced replication of 3TC‐resistant HIV‐1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.
The EMBO Journal · 1996 · https://doi.org/10.1002/j.1460-2075.1996.tb00777.x

No projects listed.